Skip to main content

Table 3 Unadjusted adherence to quality-of-care indicators by payer status (%)a

From: The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: a comprehensive study covering diagnosis, treatment, and outcomes

Indicators (No. eligible)

Overall

High reimbursement rate

Low reimbursement rate

P

ECT and brain MRI or CT (752)

57.58

60.92

54.33

0.0677

PFTs (1909)

81.72

76.65

87.85

<.0001

EGFR mutation test (453)

3.31

4.76

1.49

0.0533

ACT (938)

48.84

52.24

44.69

0.0484

Recommended for ACT (533)

44.09

48.26

37.96

0.0187

PORT (1376)

1.82

2.88

0.49

0.0010

ACT response assessment (659)

53.41

59.41

47.02

0.0014

First-line chemotherapy (977)

69.54

68.60

70.56

0.5087

Lobectomy (559)

84.97

83.18

87.61

0.1505

Surgical resection (1434)

96.16

96.85

95.32

0.1342

Combination therapy (747)

61.58

60.87

62.27

0.6942

Complications (1916)

5.53

5.42

5.66

0.8181

Metastases (1916)

9.65

10.75

8.09

0.0488

In-hospital mortality (2643)

2.65

3.66

1.47

0.0005

2-year mortality rate (825)

21.45

19.72

22.80

0.2862

total length of hospital stay (2643)

21.11 ± 16.76

21.30 ± 16.56

20.89 ± 17.00

0.0672

preoperative length of hospital stay (1916)

7.56 ± 6.55

7.84 ± 6.27

7.22 ± 6.86

<.0001

  1. aDiscrete variables were expressed as counts (%) and continuous variables were expressed as a mean ± range. Abbreviations: ECT and brain MRI or CT skeletal scintigraphy and brain magnetic resonance imaging or computed tomography, PFTS pulmonary function tests, EGFR epidermal growth factor receptor, ACT adjuvant chemotherapy, PORT postoperative radiation therapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us